Reagents News and Research

RSS

Mouse virus not responsible for Chronic Fatigue Syndrome, new study finds

Two years ago, a widely publicized scientific report plucked an old mouse virus out of obscurity and held it up as a possible cause of Chronic Fatigue Syndrome. According to a new study published today by a group of researchers in California, Wisconsin and Illinois, that report was wrong.

1 Jun 2011

Chronic fatigue syndrome and mouse virus – no association

An earlier study published in 2009 had claimed that a mouse virus was the cause of chronic fatigue syndrome. New evidence suggests that this assumption is wrong. According to latest evidence the earlier study findings were likely based on contaminated lab samples, US researchers said Tuesday.

1 Jun 2011

Complementary technologies for rapid EHEC identification and detection

With the recent outbreak in Europe of Enterohaemorrhagic Escherichia coli (EHEC), Roche Applied Science and TIB Molbiol are providing scientists with complementary technologies that can be used for the rapid identification and detection of EHEC.

30 May 2011

IT-IS Life Sciences, Roche sign exclusive distribution agreement for new LightCycler Nano Instrument

Roche Applied Science has signed a worldwide exclusive OEM agreement with IT-IS Life Sciences Ltd for the distribution of the new LightCycler Nano Instrument, which will complete the company´s portfolio for the low throughput real-time PCR systems market.

30 May 2011

Cellix Inks OEM supply agreement with Cell Biolabs

Cellix are pleased to announce the signing of an OEM manufacture and supply agreement with Cell Biolabs on a range of microfluidic biochips and accessories for cell-based assays. Cell-Biolabs, based in San Diego, CA, will supply the biochips from their current Cell-Based Assay product range thereby diversifying their product portfolio and entering into the microfluidics field.

23 May 2011

Roche's new cobas TaqScreen MPX viral discriminatory test, v2.0 now available in Europe

Roche announced today that the cobas TaqScreen MPX Test, version 2.0 for use on the cobas s 201 system is now commercially available in Europe.

23 May 2011

Automated microfluidic device can monitor hematopoietic stem cells

A Canadian research team has developed an automated microfluidic cell culture platform to monitor the growth, survival and responses of hundreds of hematopoietic stem cells at the single cell level.

23 May 2011

Gen-Probe seeks FDA regulatory clearance for PANTHER fully automated and integrated molecular testing system

Gen-Probe Incorporated announced today that the Company has filed a 510(k) application with the US Food and Drug Administration for its PANTHER system, a fully automated and integrated molecular testing system designed with the flexibility to handle a wide range of testing needs.

20 May 2011

USPTO grants four key patents for Alvine's proteases to detect celiac disease

Alvine Pharmaceuticals, Inc., a biopharmaceutical company focused on the treatment of autoimmune and gastrointestinal diseases, today announced that the United States Patent and Trademark Office has issued four key patents: 7,943,312; 7,928,056; 7,923,532; and 7,910,541, protecting various aspects of Alvine's core technology.

19 May 2011

ProBioGen, Life Technologies' new cell line development kits now available for biologic drug production

Life Technologies Corporation and ProBioGen AG today announced the availability of Gibco Freedom Cell Line Development Kits, a new line of royalty-free products that integrate cells, reagents, culture media and protocols to bring simplicity and flexibility, eliminating up to two months in the earliest stages of new biological drug development.

17 May 2011

Fluidigm launches 192.24 Dynamic Array integrated fluidic circuit for genome studies

Fluidigm Corporation today introduced its 192.24 Dynamic Array™ IFC, designed to genotype 192 samples against 24 SNP assays in a single run, providing 4,608 data points in just one hour. The 192.24 integrated fluidic circuit (IFC) has immediate applicability in agricultural biotechnology and genome wide association studies.

16 May 2011

Techulon receives U.S. patent protection for Glycofect Discovery and Therapeutic Delivery Platform

Techulon, Inc. announced today that its Glycofect Discovery and Therapeutic Delivery Platform has been awarded United States patent protection. The patented invention provides a new class of non-viral transfection vectors based on synthetic carbohydrate containing polyamides that can be used for both in vivo and in vitro applications.

16 May 2011

Researchers help explain why smart drugs are not effective in some cancer patients

Some of the most effective and expensive cancer drugs, dubbed "smart drugs" for their ability to stop tumors by targeting key drivers of cancer cell growth, are not effective in some patients. In two related studies, Yale School of Medicine researchers examined one such driver, the EGF receptor, and found that a decoy receptor might be limiting the amount of drug that gets to the intended target.

12 May 2011

Three Ontario projects set to further knowledge and discovery in biomonitoring, drug development

As part of the Genome Canada Large-Scale Applied Research Project Competition, which as a whole awarded over $58 million to 16 projects across the country, the researchers in Ontario will be focusing on biomonitoring, understanding gene function with the aim of identifying genes or proteins for drug targets, and the creation of synthetic antibodies to target cancers and other diseases.

9 May 2011

FDA clears Affymetrix's new gene profiling reagents for use in microarray instrument system

Affymetrix, Inc. today announced that the U.S. Food and Drug Administration has cleared the addition of new gene expression reagents as accessories to its GeneChip Microarray Instrument System for in vitro diagnostic use, making Affymetrix the first in the industry to provide a comprehensive microarray-based clinical toolkit for diagnostic test development, signature discovery for companion diagnostics, and translational initiatives. Affymetrix Gene Profiling Reagents offer unparalleled convenience by simplifying assay workflow, decreasing hands-on time, and reducing quality control testing compared to research-use-only-produced products.

9 May 2011

Epigenomics, Life Technologies enter supply agreement for second-generation colorectal cancer blood test

Epigenomics AG, the cancer molecular diagnosis company, today announced the signing of a supply agreement with Life Technologies Corporation, a global provider of innovative life science solutions.

7 May 2011

Fluidigm ships over 1 billion microscopic NanoFlex valves

Fluidigm today announced that its Singapore factory has manufactured and shipped more than 1 billion microscopic NanoFlex™ valves. Each NanoFlex valve is so small that it takes 10 to span the width of a human hair.

5 May 2011

Study: XMRV retrovirus is not present in chronic fatigue syndrome patients

New findings from University of Utah School of Medicine researchers show that the retrovirus called XMRV is not present in the blood of patients who have chronic fatigue syndrome.

5 May 2011

Rockland produces new Anti-NF-κB monoclonal antibody

Rockland Immunochemicals has produced a new Anti-NF-κB monoclonal antibody validated by several assays relevant for discovery including immunofluorescence microscopy, immunohistochemistry, western blotting and ELISA.

5 May 2011

Techne net earnings decrease 4.1% to $31.1 million for quarter ended March 31, 2011

Techne Corporation's consolidated pretax net earnings for the quarter ended March 31, 2011 increased 9.5% to $45.4 million compared with $41.4 million for the quarter ended March 31, 2010, mainly as a result of increased sales and foreign exchange transaction gains, partially offset by increased selling, general and administrative expenses.

From BiosPacific, Inc. 3 May 2011

Reagents News and Research

Mouse virus not responsible for Chronic Fatigue Syndrome, new study finds

Chronic fatigue syndrome and mouse virus – no association

Complementary technologies for rapid EHEC identification and detection

IT-IS Life Sciences, Roche sign exclusive distribution agreement for new LightCycler Nano Instrument

Cellix Inks OEM supply agreement with Cell Biolabs

Roche's new cobas TaqScreen MPX viral discriminatory test, v2.0 now available in Europe

Automated microfluidic device can monitor hematopoietic stem cells

Gen-Probe seeks FDA regulatory clearance for PANTHER fully automated and integrated molecular testing system

USPTO grants four key patents for Alvine's proteases to detect celiac disease

ProBioGen, Life Technologies' new cell line development kits now available for biologic drug production

Fluidigm launches 192.24 Dynamic Array integrated fluidic circuit for genome studies

Techulon receives U.S. patent protection for Glycofect Discovery and Therapeutic Delivery Platform

Researchers help explain why smart drugs are not effective in some cancer patients

Three Ontario projects set to further knowledge and discovery in biomonitoring, drug development

FDA clears Affymetrix's new gene profiling reagents for use in microarray instrument system

Epigenomics, Life Technologies enter supply agreement for second-generation colorectal cancer blood test

Fluidigm ships over 1 billion microscopic NanoFlex valves

Study: XMRV retrovirus is not present in chronic fatigue syndrome patients

Rockland produces new Anti-NF-κB monoclonal antibody

Techne net earnings decrease 4.1% to $31.1 million for quarter ended March 31, 2011

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News